Department of Neurology, State University of New York (SUNY) at Buffalo School of Medicine, Buffalo, NY, USA.
Mult Scler. 2010 Feb;16(2):228-37. doi: 10.1177/1352458509354552. Epub 2009 Dec 22.
The MS Functional Composite (MSFC) is a continuous scale of neurological disability for patients with multiple sclerosis (MS). Cognition is represented by the Paced Auditory Serial Addition Test (PASAT), although the Symbol Digit Modalities Test (SDMT) has been proposed as a promising alternative. MSFC scores were calculated using either the PASAT or the SDMT with the following reference populations: National Multiple Sclerosis Society (NMSS) Task Force, 400 MS patients, and 100 normal controls. A subgroup of 115 patients was followed longitudinally, with a test-retest interval of 2.3 +/- 1.2 years. Pearson correlations were calculated and analyses of variance (ANOVAs) were used to assess relationships among the MSFC components and composite scores, and differences in performance between patients and controls. Longitudinal changes were also assessed. Logistic regression was performed to determine which MSFC scores are most predictive of diagnosis, course, and work disability. All MSFCs had similar test-retest reliability and correlations with other measures including neurological disability, depression, and fatigue. The SDMT showed slightly better validity with respect to predicting diagnosis, course, and work disability, although the amount of variance accounted for was similar for each version of the MSFC. Our data, derived from a large sample of MS patients and normal controls, supports the validity of both PASAT and SDMT versions of the MSFC. Because the SDMT has slightly better predictive validity and has a relatively easier administration procedure, some clinicians and researchers may wish to replace the PASAT with the SDMT in future calculations of the MSFC using the calculation methods provided in this manuscript.
多发性硬化症功能综合评定量表(MSFC)是一种用于评估多发性硬化症(MS)患者神经功能障碍的连续量表。认知功能由听觉连续加法测验(PASAT)来评估,尽管符号数字模态测验(SDMT)已被提出作为一种有前途的替代方法。MSFC 评分使用 PASAT 或 SDMT 计算,参考人群为:国家多发性硬化症学会(NMSS)工作组、400 名 MS 患者和 100 名正常对照。115 名患者进行了纵向随访,测试-重测间隔为 2.3±1.2 年。计算了 Pearson 相关系数,并进行方差分析(ANOVA),以评估 MSFC 各组成部分和综合评分之间的关系,以及患者和对照组之间的表现差异。还评估了纵向变化。进行逻辑回归以确定哪些 MSFC 评分对诊断、病程和工作能力障碍最具预测性。所有 MSFC 的重测信度和与其他测量结果(包括神经功能障碍、抑郁和疲劳)的相关性相似。SDMT 在预测诊断、病程和工作能力障碍方面的有效性略好,尽管两种 MSFC 版本的解释方差相似。我们的数据来自大量 MS 患者和正常对照,支持 PASAT 和 SDMT 版本的 MSFC 的有效性。由于 SDMT 在预测有效性方面略有优势,且其测试程序相对简单,因此在未来使用本研究提供的计算方法计算 MSFC 时,一些临床医生和研究人员可能希望用 SDMT 替代 PASAT。